5 Popular Penny Stocks On Robinhood

3. Taysha Gene Therapies, Inc. (NASDAQ:TSHA)

Share Price as of October 27: $1.82

Number of Hedge Fund Holders: 13

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) is a clinical-stage gene therapy company that is involved in the development and commercialization of gene therapies for the treatment of monogenic central nervous system disorders. On August 11, Taysha Gene Therapies, Inc. (NASDAQ:TSHA) announced that it has cash and cash equivalents of $66.2 million and can continue to fund its operating expenses into the fourth quarter of 2023. The stock is one of the best penny stocks to buy now.

This August, Wedbush analyst Laura Chico revised her price target on Taysha Gene Therapies, Inc. (NASDAQ:TSHA) to $5 from $9 and maintained an Outperform rating on the shares. On October 26, Baird analyst Jack Allen adjusted his price target on Taysha Gene Therapies, Inc. (NASDAQ:TSHA) to $21 from $26 and reiterated an Outperform rating on the shares.

At the end of Q2 2022, 13 hedge funds held stakes in Taysha Gene Therapies, Inc. (NASDAQ:TSHA). The total value of these stakes amounted to $14.7 million. This is compared to 10 positions in the previous quarter with stakes worth $17.7 million. As of June 30, Nantahala Capital Management is the largest investor in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) and has stakes of $6.1 million in the company.